Core Genetics LG Corp’s goal is to develop low cost point of care products —improving patient quality of life everyday by providing decentralized screening.



Core Genetics Laboratories Group Corporation “CoreGen” was founded in 2009, embrace a new and exciting era of next generation sequencing (NGS) and complementary OMICS technological BIG data revolution.

CoreGen is a privately funded research and development company with continual joint ventures comprising several New York academic research institutions to foster a common mission to develop the new generation of cancer diagnostics that are cost-conscious, and portable for improving cancer care management worldwide.

With our expertise in massively parallel sequencing, and high content screening, we have pioneered this synergistic platform for development of rapid cancer diagnostic tests. Our unique specialty includes, NGS, Cancer screening and diagnostics.